Comparing the Effectiveness of Papain Based Chemico-mechanical Caries Removal Gel and 38% Silver Diamine Fluoride for Treating Active Caries Lesion of Primary Molars
Launched by AL-MUSTANSIRIYAH UNIVERSITY · May 8, 2024
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for cavities in children's teeth, specifically in primary molars (the back teeth that children use for chewing). The researchers want to see how effective a gel containing papain (which helps remove decay) compares to a well-known treatment called silver diamine fluoride (SDF). They will also look at how long each treatment takes, whether any side effects occur, and how anxious the children feel during the treatment.
To participate in the trial, children aged 7 to 8 years old must have cavities in their primary molars that are not too deep and do not touch the nerve of the tooth. Children will not be included if they have allergies to the study treatments or other health concerns. While the trial is currently active, no new participants are being recruited. Parents can expect their children to receive one of the two treatments and to be monitored for any reactions or feelings of anxiety during the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each child should have primary molars with open carious lesions, either on the occlusal surface or Proximal one with the absence of a neighboring tooth.
- • These lesions should affect the dentin but not expose the pulp.
- • The depth of the cavities should measure between 40-99 using a DIAGNOdent caries detection instrument for standardization
- Exclusion Criteria:
- • Children were excluded if parents were unwilling to be assigned to any of the approaches
- • Children that had any abnormal medical condition or silver or papain allergy
- • Chose molars with clinical or radiographic signals of pulp involvement
About Al Mustansiriyah University
Al-Mustansiriyah University is a prominent academic institution located in Baghdad, Iraq, dedicated to advancing education, research, and healthcare. As a clinical trial sponsor, the university leverages its expertise in medical and scientific research to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodologies, Al-Mustansiriyah University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and reliability of its clinical trials, ultimately striving to enhance public health and advance medical practices within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, Al Karkh, Iraq
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported